These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
79 related articles for article (PubMed ID: 17344578)
1. NT-proBNP and the diagnosis of left ventricular systolic dysfunction within two acute NHS trust catchment areas: the initial Teesside experience. Turley AJ; Roberts AP; Davies A; Rowell N; Drury J; Smith RH; Shyam-Sundar A; Stewart MJ Postgrad Med J; 2007 Mar; 83(977):206-8. PubMed ID: 17344578 [TBL] [Abstract][Full Text] [Related]
2. Head to head comparison of N-terminal pro-B-type natriuretic peptide and B-type natriuretic peptide in patients with/without left ventricular systolic dysfunction. Vanderheyden M; Bartunek ; Claeys G; Manoharan G; Beckers JF; Ide L Clin Biochem; 2006 Jun; 39(6):640-5. PubMed ID: 16516185 [TBL] [Abstract][Full Text] [Related]
3. Diagnostic value of N-terminal pro-B-type natriuretic peptide (NT-proBNP) for left ventricular dysfunction in patients with chronic kidney disease stage 5 on haemodialysis. David S; Kümpers P; Seidler V; Biertz F; Haller H; Fliser D Nephrol Dial Transplant; 2008 Apr; 23(4):1370-7. PubMed ID: 18089624 [TBL] [Abstract][Full Text] [Related]
4. Accuracy of N-terminal pro-brain natriuretic peptide in the identification of left ventricular dysfunction in high-risk asymptomatic patients. Romano S; Necozione S; Guarracini L; Fratini S; Cisternino P; di Orio F; Penco M J Cardiovasc Med (Hagerstown); 2009 Mar; 10(3):238-44. PubMed ID: 19262210 [TBL] [Abstract][Full Text] [Related]
5. [Personal experience with determination of NT-proBNP in clinical practice]. Stejskal D; Oral I; Lacnák B; Juráková R; Horalík D; Adamovská S; Prosková J; Hrabovská I; Ozanová G Vnitr Lek; 2003 Feb; 49(2):121-6. PubMed ID: 12728579 [TBL] [Abstract][Full Text] [Related]
6. Midregional pro-atrial natriuretic peptide is a useful indicator for the detection of impaired left ventricular function in patients with coronary artery disease. Elmas E; Brueckmann M; Lang S; Kälsch T; Haghi D; Sueselbeck T; Dempfle CE; Borggrefe M Int J Cardiol; 2008 Aug; 128(2):244-9. PubMed ID: 17673312 [TBL] [Abstract][Full Text] [Related]
7. B-type natriuretic peptide (BNP) and N-terminal-proBNP for heart failure diagnosis in shock or acute respiratory distress. Bal L; Thierry S; Brocas E; Van de Louw A; Pottecher J; Hours S; Moreau MH; Perrin Gachadoat D; Tenaillon A Acta Anaesthesiol Scand; 2006 Mar; 50(3):340-7. PubMed ID: 16480468 [TBL] [Abstract][Full Text] [Related]
8. Ruling out heart failure in primary-care: the cost-benefit of pre-screening using NT-proBNP and QRS width. Goode KM; Clark AL; Cleland JG Int J Cardiol; 2008 Nov; 130(3):426-37. PubMed ID: 18178273 [TBL] [Abstract][Full Text] [Related]
9. Amino-terminal pro-B-type natriuretic peptide testing for the diagnosis or exclusion of heart failure in patients with acute symptoms. Januzzi JL; Chen-Tournoux AA; Moe G Am J Cardiol; 2008 Feb; 101(3A):29-38. PubMed ID: 18243855 [TBL] [Abstract][Full Text] [Related]
11. Comparative value of BNP and NT-proBNP in diagnosis of heart failure. Fonseca C; Sarmento PM; Minez A; Gonçalves E; Covas R; Dias AR; Pina MJ; Ceia F Rev Port Cardiol; 2004; 23(7-8):979-91. PubMed ID: 15478324 [TBL] [Abstract][Full Text] [Related]
12. Plasma pro-B-type natriuretic peptide in the general population: screening for left ventricular hypertrophy and systolic dysfunction. Goetze JP; Mogelvang R; Maage L; Scharling H; Schnohr P; Sogaard P; Rehfeld JF; Jensen JS Eur Heart J; 2006 Dec; 27(24):3004-10. PubMed ID: 17118955 [TBL] [Abstract][Full Text] [Related]
13. The diagnostic utility of N-terminal pro-B-type natriuretic peptide for the detection of major structural heart disease in patients with atrial fibrillation. Shelton RJ; Clark AL; Goode K; Rigby AS; Cleland JG Eur Heart J; 2006 Oct; 27(19):2353-61. PubMed ID: 16952921 [TBL] [Abstract][Full Text] [Related]
14. Screening the population for left ventricular hypertrophy and left ventricular systolic dysfunction using natriuretic peptides: results from the Dallas Heart Study. de Lemos JA; McGuire DK; Khera A; Das SR; Murphy SA; Omland T; Drazner MH Am Heart J; 2009 Apr; 157(4):746-53.e2. PubMed ID: 19332205 [TBL] [Abstract][Full Text] [Related]
15. Cutoff values of NT-proBNP for the prediction of low functional capacity, decreased ejection fraction and cardiovascular events in patients with heart failure. Koç M; Bozkurt A; Yildiray-Sahin D; Unal I; Acartürk E Cardiol J; 2009; 16(1):43-9. PubMed ID: 19130415 [TBL] [Abstract][Full Text] [Related]
16. Plasma amino-terminal pro-brain natriuretic peptide: a novel approach to the diagnosis of cardiac dysfunction. Campbell DJ; Mitchelhill KI; Schlicht SM; Booth RJ J Card Fail; 2000 Jun; 6(2):130-9. PubMed ID: 10908087 [TBL] [Abstract][Full Text] [Related]
17. Reliability of N-terminal proBNP assay in diagnosis of left ventricular systolic dysfunction within representative and high risk populations. Hobbs FD; Davis RC; Roalfe AK; Hare R; Davies MK Heart; 2004 Aug; 90(8):866-70. PubMed ID: 15253955 [TBL] [Abstract][Full Text] [Related]
18. N-terminal pro-brain natriuretic peptide (NT-proBNP) in healthy blood donors and in patients from general practitioners with and without a diagnosis of cardiac disease. Hess G; Runkel S; Zdunek D; Hitzler WE Clin Lab; 2005; 51(3-4):167-72. PubMed ID: 15819172 [TBL] [Abstract][Full Text] [Related]
19. Diagnostic accuracy of B type natriuretic peptide and amino terminal proBNP in the emergency diagnosis of heart failure. Mueller T; Gegenhuber A; Poelz W; Haltmayer M Heart; 2005 May; 91(5):606-12. PubMed ID: 15831643 [TBL] [Abstract][Full Text] [Related]
20. Left ventricular dysfunction and NT-proBNP levels in patients with one-vessel disease after first ST-elevation myocardial infarction treated with primary coronary angioplasty. Szadkowska I; Pawlicki L; Kowalski J; Banach M; Goch JH; Chizyński K Kardiol Pol; 2009 Nov; 67(11):1201-6. PubMed ID: 20024847 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]